https://www.selleckchem.com/products/azd9291.html
all of which may ultimately improve patient health and well-being outcomes. Repository corticotropin injection (RCI; Acthar Gel) is indicated to induce a diuresis or a remission of proteinuria in nephrotic syndrome (NS) without uremia of the idiopathic type or that due to lupus erythematosus. This study compares patient characteristics and measurable healthcare resource utilization (HCRU) between NS patients who received a prescription for RCI and then were either approved or denied treatment by their insurers. A retrospective analysis
Like
Comment
Share
